Pathalys Pharma

Updated: August 06, 2025

CEO - Neal Fowler

Country: USA | Funding: $266M (+)

Website: https://pathalys.com

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Competitors